Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.